Both in Pharmaceuticals
Arcus Biosciences vs Immunome
Over the past year RCUS returned −7.1% and IMNM returned +19.5%; their daily moves had a correlation of 0.34.
RCUS −7.1% IMNM +19.5%Growth of $1, one year, split-adjusted
| Metric | RCUS | IMNM |
|---|---|---|
| Price | $18.91 | $20.31 |
| Market cap | $2.41B | $2.40B |
| Today | +5.94% | +3.68% |
| 1 month | −23.6% | −4.1% |
| 6 months | −27.4% | −12.1% |
| Year to date | −20.6% | −5.4% |
| 1 year | −4.1% | +26.4% |
| Revenue growth (YoY) | −74.4% | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | −222.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 20.6× | — |
| Net cash | $601.0M | $520.0M |
| Dividend yield | — | — |
| Volatility (60d) | 64.0% | 57.8% |
| Short % of float | 13.6% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).